Barclays PLC Makes New $429,000 Investment in Grail, Inc. (NASDAQ:GRAL)

Barclays PLC bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, Holdings Channel reports. The fund bought 24,107 shares of the company’s stock, valued at approximately $429,000.

Other large investors have also modified their holdings of the company. Crcm LP bought a new position in Grail in the fourth quarter worth approximately $65,061,000. Primecap Management Co. CA bought a new position in Grail in the fourth quarter worth about $37,118,000. Vanguard Group Inc. purchased a new stake in shares of Grail during the fourth quarter valued at about $25,902,000. Arbiter Partners Capital Management LLC bought a new stake in shares of Grail in the 4th quarter valued at about $14,827,000. Finally, Geode Capital Management LLC purchased a new position in shares of Grail in the 4th quarter worth approximately $7,920,000.

Insiders Place Their Bets

In other news, CFO Aaron Freidin sold 1,816 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares of the company’s stock, valued at $10,457,304. This represents a 0.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Robert P. Ragusa sold 94,035 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer now owns 734,627 shares in the company, valued at $24,925,894.11. The trade was a 11.35 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 194,948 shares of company stock valued at $6,583,130.

Grail Trading Down 2.5 %

GRAL stock opened at $35.20 on Friday. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The firm has a 50 day moving average of $29.54 and a 200 day moving average of $25.70.

Grail (NASDAQ:GRAL) last posted its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. As a group, analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on GRAL shares. Canaccord Genuity Group assumed coverage on shares of Grail in a research note on Monday, April 21st. They issued a “buy” rating and a $32.00 target price for the company. Morgan Stanley raised their price objective on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 18th.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.